Strategic Acquisition Monocl is now part of Definitive Healthcare, signaling a consolidation of healthcare commercial intelligence capabilities. This presents a sales opportunity to cross-sell Definitive Healthcare’s enhanced SaaS platform and expanded data assets to former Monocl clients and to identify new market segments now served under a unified offering.

Data-Driven Engagement Leverage Definitive Healthcare’s emphasis on data, analytics and expert networks to position enhanced market intelligence and advisory capabilities to life sciences teams seeking to identify and engage key opinion leaders, investigators, and digital influencers across geographies and therapeutic areas.

Product Enhancement Momentum Recent product enhancements announced by Definitive Healthcare imply ongoing investments in platform capabilities. Use this to create urgency with prospects by highlighting new features that improve market visibility, faster decision-making, and sharper targeting for investigator and provider engagement.

Strategic Partnerships Partnerships and collaborations (examples with Emporia Research and industry events) indicate a growing ecosystem around Definitive Healthcare. Target prospects who value integrated workflows with benchmarking, recruitment efficiency, and broader data interoperability to accelerate go-to-market and patient activation initiatives.

Competitive Positioning Given the overlapping functions with large players and the high emphasis on healthcare market intelligence, position Definitive Healthcare as the end-to-end platform combining data, analytics, and expert networks to outperform competitors in speed, accuracy, and geographic reach for life sciences commercialization.